Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis.
Silverberg JI, Gooderham M, Katoh N, Aoki V, Pink AE, Binamer Y, Rademaker M, Fomina D, Gutermuth J, Ahn J, Valenzuela F, Ameen M, Steinhoff M, Kirchhof MG, Lio P, Wollenberg A. Silverberg JI, et al. Among authors: valenzuela f. J Eur Acad Dermatol Venereol. 2024 Nov;38(11):2139-2148. doi: 10.1111/jdv.20229. Epub 2024 Jul 11. J Eur Acad Dermatol Venereol. 2024. PMID: 38989857
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study.
Caron AGM, van Huizen AM, Musters AAH, Gerbens LAA, Middelkamp Hup MA, Flohr C, Irvine AD, Vestergaard C, Peris K, Brandling-Bennett HA, Drucker AM, Spuls PI; MTX Consensus for AD Survey Study Group. Caron AGM, et al. J Eur Acad Dermatol Venereol. 2024 Aug 1. doi: 10.1111/jdv.20271. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39087636
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Global Comparison of COVID-19 Vaccination Rates among Psoriasis Patients.
Korouri E, Jeong C, Peterson H, Valenzuela F, Romiti R, Didaskalu JA, Egeberg A, Oon HH, Maul LV, Kingston P, Lee K, Huang MY, Yee D, Artiga K, Aguero R, Maul JT, Armstrong AW. Korouri E, et al. Among authors: valenzuela f. Life (Basel). 2024 Oct 13;14(10):1297. doi: 10.3390/life14101297. Life (Basel). 2024. PMID: 39459597 Free PMC article.
The role of excimer light in dermatology: a review.
Hartmann Schatloff D, Retamal Altbir C, Valenzuela F. Hartmann Schatloff D, et al. Among authors: valenzuela f. An Bras Dermatol. 2024 Nov-Dec;99(6):887-894. doi: 10.1016/j.abd.2023.12.007. Epub 2024 Aug 5. An Bras Dermatol. 2024. PMID: 39107199 Free PMC article. Review.
Preparation and Characterization of Lignin Nanoparticles from Different Plant Sources.
Ortega-Sanhueza I, Girard V, Ziegler-Devin I, Chapuis H, Brosse N, Valenzuela F, Banerjee A, Fuentealba C, Cabrera-Barjas G, Torres C, Méndez A, Segovia C, Pereira M. Ortega-Sanhueza I, et al. Among authors: valenzuela f. Polymers (Basel). 2024 Jun 6;16(11):1610. doi: 10.3390/polym16111610. Polymers (Basel). 2024. PMID: 38891555 Free PMC article.
Lobectomy in patients with differentiated thyroid cancer: experience of a Chilean tertiary center.
Fuentes I, Santana R, Espinoza M, Arteaga E, Uslar T, Baudrand R, González G, Guarda FJ, Lustig N, Mosso L, Nilo F, Valenzuela F, Domínguez F, González HE, Montero PH, Cruz F, Solar A, Domínguez JM. Fuentes I, et al. Among authors: valenzuela f. Endocrine. 2024 Nov;86(2):692-698. doi: 10.1007/s12020-024-03905-1. Epub 2024 Jun 14. Endocrine. 2024. PMID: 38874828
236 results